文献速递肿瘤 PET/CT放射性药物与辐射防护

68Ga-DOTATATE PET/CT在前列腺炎中的假阳性表现

False-Positive 68Ga-DOTATATE PET/CT in Active Chronic Prostatitis.
PubMed 文献 · Clin Nucl Med · 2019-01-01

一例66岁中肠神经内分泌肿瘤术后患者行68Ga-DOTATATE PET/CT再分期,前列腺弥漫高摄取,活检证实为活动性慢性前列腺炎,提示前列腺炎可致该显像假阳性。

要点

  • 前列腺弥漫性高摄取需鉴别前列腺炎与肿瘤,避免误判为转移或第二原发。
  • 活动性慢性前列腺炎是68Ga-DOTATATE PET/CT前列腺假阳性的潜在原因。
  • 对前列腺局灶或弥漫摄取,应结合PSA、炎症指标及活检综合判断。

核心结论

  • 活动性慢性前列腺炎可导致68Ga-DOTATATE PET/CT前列腺弥漫性高摄取,形成假阳性。

研究设计与样本

  • 单例病例报告:66岁男性中肠神经内分泌肿瘤术后行68Ga-DOTATATE PET/CT再分期,前列腺摄取经穿刺活检证实。

主要发现

  • 68Ga-DOTATATE PET/CT未见原发肿瘤残留可疑摄取,但前列腺弥漫高摄取,提示前列腺炎或第二原发肿瘤。
  • 同期PSA为5.02 ng/mL(参考范围0-4 ng/mL),CRP为8.25 mg/L(参考范围<5 mg/L),白细胞计数为6.83 × 10/μL(参考范围3.9-10.9 × 10/μL)。
  • 前列腺穿刺活检确诊活动性慢性前列腺炎,被认定为该假阳性弥漫摄取的原因。

关键数值与推荐

  • PSA 5.02 ng/mL(参考范围0-4 ng/mL)升高,CRP 8.25 mg/L(参考范围<5 mg/L)升高,白细胞计数6.83 × 10/μL在参考范围3.9-10.9 × 10/μL内。

临床怎么用

  • 对68Ga-DOTATATE PET/CT前列腺弥漫高摄取,应结合PSA、CRP及白细胞等指标,必要时行前列腺活检以排除前列腺炎所致假阳性。

局限性

  • 单例病例报告,不能推断总体发生率或因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 66-year-old man with neuroendocrine tumor originating from midgut was referred to Ga-DOTATATE PET/CT imaging for restaging postoperatively. No suspicious uptake regarding residual primary tumoral involvement was seen. But there was diffuse high uptake in prostate gland suggestive of prostatitis or secondary primary tumoral lesion. Concurrent prostate-specific antigen level was 5.02 ng/mL (range, 0-4 ng/mL), C-reactive protein level was 8.25 mg/L (range, <5 mg/L), and white blood cell count was 6.83 × 10/μL (range, 3.9-10.9 × 10/μL). Diagnosis of active chronic prostatitis was achieved by core biopsy, which is identified as potential cause for false-positive diffuse uptake on Ga-DOTATATE PET/CT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yilmaz B, Arslan HS, Gundogan C, et al. False-Positive 68Ga-DOTATATE PET/CT in Active Chronic Prostatitis. Clin Nucl Med. 2019. PMID: 31274635. doi:10.1097/RLU.0000000000002594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。